Isotretinoin Capsule, Liquid Filled
Product Images NDC 0832-8301

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Isotretinoin (NDC 0832-8301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Isotretinoin 01)

FDA Label Image

Chemical Structure (Isotretinoin 02)

FDA Label Image

Principal Display Panel (10 mg Blister Pack Box)

Principal Display Panel (10 mg Blister Pack Box)
This is a medication description for Isotretinoin Capsules. Each capsule contains 10 mg of Isotretinoin and it is only available with a prescription. It is contraindicated in pregnancy as it may cause birth defects. Pharmacists are required to dispense no more than a 30-day supply and to dispense intact prescription packs. A medication guide is included in each prescription pack. The medication should be stored at 20° to 25°C and protected from light. For dosages and prescribing information, the accompanying insert should be read. Made in Switzerland, distributed by Upsher-Smith Laboratories, LLC in Maple Grove, MN.*
FDA Label Image

Principal Display Panel (20 mg Blister Pack Box)

Principal Display Panel (20 mg Blister Pack Box)
Isotretinoin capsules are a prescription medication containing 20 mg of isotretinoin USP, and each box contains 30 capsules. The drug is contraindicated for use during pregnancy because it can cause birth defects. Only prescribed packs must be dispensed intact and patients enrolled and authorized by the iPLEDGE REMS can receive isotretinoin. Physicians should only prescribe the recommended dose and follow the advisory insert. It must be stored at controlled room temperature and protected from light.*
FDA Label Image

Principal Display Panel (30 mg Blister Pack Box)

Principal Display Panel (30 mg Blister Pack Box)
Isotretinoin is a medication available in capsules of 30mg, prescribed only with an authorization from the iPLEDGE REMS program to prevent pregnant women or those planning to be pregnant from using it, since it can cause birth defects. It should be stored between 20°C and 25°C, with no contact with light. Pharmacists must dispense the medication in intact prescription packs, not allowing refills or dispensing after the "Do not dispense to Patient After" date. Each pack must include a Medication Guide which provides the necessary information for usage and dosages.*
FDA Label Image

Principal Display Panel (40 mg Blister Pack Box)

Principal Display Panel (40 mg Blister Pack Box)
Isotretinoin Capsules, USP with 40mg strength and 30 capsules per prescription pack is contraindicated in pregnancy as it can cause birth defects. It is only to be dispensed for enrolled patients after obtaining authorization from the iPLEDGE REMS and pharmacists are reminded not to dispense after the expiration date, dispense no more than a 30-day supply and preserve Prescription Packs intact.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.